Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
84 hedge funds and large institutions have $370M invested in Inari Medical, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
15.99% more ownership
Funds ownership: 0% → 15.99% (+16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$44.8M |
| 2 |
PA
Perceptive Advisors
New York
|
+$33.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$31.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.3M |
Top Sellers
NARI Hedge Fund Activity: Q2 2020 in Review
84 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q2 2020, worth a combined $370M.
Buyers outnumbered sellers: 84 funds opened new NARI positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AllianceBernstein, opening a new position worth an estimated $44.8M.
- 84 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $370M of Inari Medical, Inc. Common Stock stock for Q2 2020.
- 84 funds opened new Inari Medical, Inc. Common Stock positions in Q2 2020 and 0 closed out, a net change of +84 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q2 2020 was AllianceBernstein, an estimated $44.8M added.
Based on aggregated 13F filings for Q2 2020.